PCN17 THE COST-EFFECTIVENESS OF CETUXIMAB IN COMBINATION WITH IRINOTECAN FORTHE TREATMENT OF PATIENTS WITH EGFR-EXPRESSING METASTATIC COLORECTAL CANCER AFTER FAILURE OF IRINOTECAN-INCLUDING CYTOTOXIC THERAPY IN SCOTLAND

Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67255-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)67255-5/fulltext
Title : PCN17 THE COST-EFFECTIVENESS OF CETUXIMAB IN COMBINATION WITH IRINOTECAN FORTHE TREATMENT OF PATIENTS WITH EGFR-EXPRESSING METASTATIC COLORECTAL CANCER AFTER FAILURE OF IRINOTECAN-INCLUDING CYTOTOXIC THERAPY IN SCOTLAND
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67255-5&doi=10.1016/S1098-3015(10)67255-5
First page :
Section Title :
Open access? : No
Section Order : 482
Categories :
Tags :
Regions :
ViH Article Tags :